Related Experiment Video
Updated: Mar 29, 2026
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
701
Transcriptomics and the mechanisms of antidepressant efficacy
Karen Hodgson1, Katherine E Tansey1, Timothy R Powell1
1MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King׳s College London, UK.
Summary
Antidepressant treatment effectiveness varies, but gene expression changes may predict outcomes. This study identified specific genes and gene networks linked to successful antidepressant response in patients with depression.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- The precise mechanisms of antidepressant action remain unclear.
- Variability in patient response to antidepressants is a significant clinical challenge.
- Previous research suggests gene expression alterations may play a role in antidepressant efficacy.
Purpose of the Study:
- To investigate transcriptome-wide gene expression changes induced by antidepressants.
- To explore the association between these gene expression alterations and treatment response in depressed patients.
- To identify potential molecular pathways involved in antidepressant therapeutic effects.
Main Methods:
- Blood samples were collected from 136 depressed patients before and after 8 weeks of escitalopram or nortriptyline treatment.
- Transcriptomic data were generated using Illumina HumanHT-12 v4 Expression BeadChip microarrays.
- Analysis focused on individual gene expression changes and coexpressed gene modules correlated with treatment response.
Main Results:
- Changes in the expression of two genes, MMP28 and KXD1, were associated with improved response to nortriptyline.
- A significant correlation was found between changes in one coexpression module and overall treatment response (cor=0.27, p=0.0029).
- These findings highlight specific gene expression patterns related to antidepressant efficacy.
Conclusions:
- Transcriptomic analysis successfully identified gene expression correlates of antidepressant therapeutic effects.
- The study points to potential molecular pathways underlying successful antidepressant treatment.
- These findings may contribute to a better understanding of personalized antidepressant therapy.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
01:25Antidepressant Drugs: Overview
2.0K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.0K
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
2.1K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.1K
01:21G-protein Coupled Receptors
134.2K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
134.2K
01:18Depression: Overview
1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
01:27Depressive Disorders: Etiology
859
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
859